Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?

Analysts' mean price target for Eton Pharmaceuticals implies a 49.3% upside. The article notes analysts are showing strong agreement in raising earnings estimates, which supports upside potential, but warns the price-target metric has not reliably predicted outcomes historically. This is a cautiously positive signal for the stock rather than a definitive catalyst.

Analysis

Analysts' mean price target for Eton Pharmaceuticals implies a 49.3% upside. The article notes analysts are showing strong agreement in raising earnings estimates, which supports upside potential, but warns the price-target metric has not reliably predicted outcomes historically. This is a cautiously positive signal for the stock rather than a definitive catalyst.